6/9/25 We are currently making changes to reflect the new Health Sciences Division structure. Thank you for your patience while we make the transition.

Sign in
Anticoagulation Strategies in Non-Critically Ill Patients with Covid-19
Journal article   Peer reviewed

Anticoagulation Strategies in Non-Critically Ill Patients with Covid-19

Zoe K McQuilten, Balasubramanian Venkatesh, Vivekanand Jha, Jason Roberts, Susan C Morpeth, James A Totterdell, Grace M McPhee, John Abraham, Niraj Bam, Methma Bandara, …
NEJM evidence, Vol.2(2), pp.EVIDoa2200293-EVIDoa2200293
02/2023
Handle:
https://hdl.handle.net/10523/19276

Abstract

Anticoagulants - pharmacology Aspirin - pharmacology Blood Coagulation COVID-19 Humans
Anticoagulation in Non-Critically Ill Covid-19 PatientsMcQuilten et al. conducted a randomized clinical trial comparing low-dose, intermediate-dose, low-dose plus aspirin, and therapeutic-dose anticoagulation in patients with Covid-19 of diverse ethnicities in high-, low-, and middle-income countries.

Details

Logo image